Theorem Clinical Research

Chiltern

Chiltern acquires Ockham, strengthening oncology, CRO services, job placement

Tuesday, July 15, 2014 03:38 PM

U.K.-based Chiltern, a 32-year-old global CRO specializing in oncology services and a range of other therapeutic areas, has acquired Ockham, a 28-year-old oncology-focused CRO, and the two companies will merge their operations.

More... »


Chiltern wins CRO leadership award from Life Science Leader

Friday, March 7, 2014 09:31 AM

Global CRO Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leaderpublication based on the data-driven research of Nice Insight. Chiltern is the only organization to be recognized in all five categories for three straight years.

More... »


Chiltern partners with Karolinska Development

Thursday, February 13, 2014 01:59 PM

Global CRO Chiltern International has partnered with Karolinska Development, a Sweden-based life science investment company. Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations, along with other cooperation agreements with universities, delivers a continuous flow of innovations.

More... »

Chiltern wins Pharmatimes awards

Thursday, February 6, 2014 11:10 AM

Global CROChiltern International has won two awards at the PharmaTimes Annual Awards 2014 ceremony that took place in London on Jan. 30. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

More... »

Kester Capital sells Chiltern

Thursday, January 2, 2014 10:54 AM

Kester Capital, the European private equity arm of Greenhill & Co., has sold its interest in Chiltern in a deal valuing the company at $223.4 million. The exit comes as Chiltern announces the consolidation of existing investors, led by Sir Douglas Myers. The transaction has generated a return of over two times capital and a 25% IRR for Kester Capital funds.

More... »

PharmaTimes recognizes top U.S. clinical researchers

Tuesday, November 19, 2013 01:00 PM

Winners of the U.S. Clinical Researcher of the Year competition were announced following an intense finals day hosted by partner SAS at its global headquarters in Cary, N.C.

More... »

Chiltern names Andrew Monaghan director, global pharmacovigilance

Friday, July 26, 2013 03:07 PM

Global CRO Chiltern International has appointed Andrew Monaghan, Ph.D., director, global pharmacovigilance. Monaghan will lead the pharmacovigilance team and expand the company’s pharmacovigilance offering.

More... »

Chiltern promotes Alecia Barbee to VP, Global Biometrics

Tuesday, June 4, 2013 12:00 PM

Global CRO Chiltern International has promoted Alecia Barbee to VP, Global Biometrics.

More... »

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

More... »

Chiltern promotes Stuart McGuire and Jim Szymeczek

Thursday, March 28, 2013 08:00 AM

Chiltern International, a global contract CRO, has promoted Stuart McGuire to the position of vice president of global business development, and Jim Szymeczek to the position of vice president of global information technology and systems.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs